Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 929033207 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
RA Capital Management, L.P.
13D/A
|
19.9% |
7/21/2026
Event 7/16/2026
|
||
| RA Capital Management, L.P. | 19.9% | |||
| Peter Kolchinsky | 19.9% | |||
| Rajeev Shah | 19.9% | |||
| RA Capital Healthcare Fund, L.P. | 19.9% | |||
|
Reprogrammed Interchange LLC
13D/A
|
17.6% |
10/17/2025
Event 10/15/2025
|
||
| Reprogrammed Interchange LLC | 17.6% | |||
| Reid Hoffman | 17.6% | |||
|
FMR LLC
13G/A
|
12.0% |
8/7/2026
Event 7/31/2026
|
||
| FMR LLC | 12.0% | |||
| Abigail P. Johnson | 12.0% | |||
|
TCG Crossover GP II, LLC
13G
|
10.5% |
4/1/2026
Event 3/30/2026
|
||
| TCG Crossover GP II, LLC | 5.2% | |||
| TCG Crossover Fund II, L.P. | 5.2% | |||
| TCG Crossover GP III, LLC | 5.2% | |||
| TCG Crossover Fund III, L.P. | 5.2% | |||
| Chen Yu | 10.5% | |||
|
ForGrowth III PA B.V.
13D
|
10.0% |
12/23/2025
Event 12/18/2025
|
||
| ForGrowth III PA B.V. | 10.0% | |||
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 10.0% | |||
| Forbion Growth III Management B.V. | 10.0% | |||
|
Venrock Healthcare Capital Partners III, L.P.
13G/A
|
9.9% |
8/14/2026
Event 6/30/2026
|
||
| Venrock Healthcare Capital Partners III, L.P. | 9.9% | |||
| VHCP Co-Investment Holdings III, LLC | 9.9% | |||
| Venrock Healthcare Capital Partners EG, L.P. | 9.9% | |||
| VHCP Management III, LLC | 9.9% | |||
| VHCP Management EG, LLC | 9.9% | |||
| Nimish Shah | 9.9% | |||
| Bong Y. Koh | 9.9% | |||
| Verve Capital Ltd 13G/A | 6.3% |
8/13/2026
Event 6/30/2026
|
||
| BlackRock, Inc. 13G | 5.7% |
7/30/2026
Event 6/30/2026
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (4) | ||||
|
Paradigm Biocapital Advisors LP
13G/A
|
4.5% |
2/17/2026
Event 12/31/2025
|
||
| Paradigm BioCapital Advisors LP | 4.5% | |||
| Paradigm BioCapital Advisors GP LLC | 4.5% | |||
| Senai Asefaw, M.D. | 4.5% | |||
| Paradigm BioCapital International Fund Ltd. | 4.0% | |||
|
Frazier Life Sciences Public Fund, L.P.
13G/A
|
4.2% |
8/14/2026
Event 6/30/2026
|
||
| Frazier Life Sciences Public Fund, L.P. | 4.2% | |||
| FHMLSP, L.P. | 4.2% | |||
| FHMLSP, L.L.C. | 4.2% | |||
| Frazier Life Sciences XI, L.P. | 0% | |||
| FHMLS XI, L.P. | 0% | |||
| FHMLS XI, L.L.C. | 0% | |||
| Frazier Life Sciences XII, L.P. | 0.5% | |||
| FHMLS XII, L.P. | 0.5% | |||
| FHMLS XII, L.L.C. | 0.5% | |||
|
Great Point Partners, LLC
13G/A
|
3.3% |
2/17/2026
Event 12/31/2025
|
||
| Great Point Partners, LLC | 3.3% | |||
| Dr. Jeffrey R. Jay, M.D. | 3.3% | |||
| Ms. Lillian Nordahl | 3.3% | |||
|
Qiming Venture Partners VIII-HC, L.P.
13G/A
|
2.0% |
5/6/2026
Event 3/31/2026
|
||
| Qiming Venture Partners VIII-HC, L.P. | 2.0% | |||
| Qiming Venture Partners VIII Investments, LLC | 1.7% | |||
| Qiming GP VIII, LLC | 1.7% | |||
| Qiming GP VIII-HC, LLC | 2.0% | |||